ABSTRACT
Magnetic resonance imaging (MRI) has emerged as a pivotal tool in contemporary medical diagnostics, offering non-invasive and high-resolution visualization of internal structures. Contrast agents are essential for enhancing MRI resolution, accurate lesion detection, and early pathology identification. While gadolinium-based contrast agents are widely used in clinics, safety concerns have prompted exploration of metal-free alternatives, including fluorine and nitroxide radical-based MRI contrast agents. Fluorine-containing compounds exhibit excellent MRI capabilities, with 19F MRI providing enhanced resolution and quantitative assessment. Nitroxide radicals, such as PROXYL and TEMPO, offer paramagnetic properties for MRI contrast. Despite their versatility, nitroxide radicals suffer from lower relaxivity values (r1) compared to gadolinium. Dual-modal imaging, combining 1H and 19F MRI, has gained prominence for its comprehensive insights into biological processes and disease states. However, existing dual-modal agents predominantly utilize gadolinium-organic ligands without incorporating nitroxide radicals. Here, we introduce a novel dual-modal MRI contrast agent (J-CA) featuring a Janus asymmetric nanostructure synthesized via seeded emulsion polymerization and post-modification. J-CA demonstrates excellent in vitro and in vivo performance in both 19F and 1H MRI, with a T2 relaxation time of 5 ms and an r1 value of 0.31 mM-1 s-1, ensuring dual-modal imaging capability. Moreover, J-CA exhibits superior biocompatibility and organ targeting, making it a promising candidate for precise lesion imaging and disease diagnosis. This work introduces a new avenue for metal-free dual-modal MRI, addressing safety concerns associated with traditional contrast agents.
Subject(s)
Contrast Media , Magnetic Resonance Imaging , Nanostructures , Polymers , Contrast Media/chemistry , Contrast Media/chemical synthesis , Magnetic Resonance Imaging/methods , Animals , Mice , Nanostructures/chemistry , Polymers/chemistry , Humans , Fluorine/chemistry , Particle SizeABSTRACT
Amide bonds are one of the most prevalent phenomena in nature and are utilized frequently in drug and material design. However, forming amide bonds is not always efficient or high yielding, particularly when the amine used to conjugate to a carboxylic acid is a weak nucleophile. This limitation precludes many useful amino compounds from participating in conjugation reactions to form amides. A particularly valuable amino compound, which is also a very weak nucleophile, is the amino porphyrin, valued for its role as a photosensitizer, fluorescent agent, catalyst, or, upon metalation, even a very efficient contrast agent for magnetic resonance imaging (MRI). In this work, we propose fast and high-yield coupling of an unreactive amine - the amino porphyrin - to carboxylic acid via isothiocyanate conjugation. Reactions can be achieved in one step at room temperature in one hour, achieving quantitative conversion and near perfect selectivity. Both metalated and unmetalated porphyrin, as well as fluorescein isothiocyanate (FITC), demonstrated efficient conjugation. To illustrate the value of the proposed method, we created a new blood-pool MRI contrast agent that reversibly binds to serum albumin. This new blood-pool agent, known as MITC-Deox (MRI isothiocyanate that links with deoxycholic acid), substantially reduced T1 relaxation times in blood vessels in mice, remained stable for 1 hour, cleared from blood by 24 hours, and was eliminated from the body after 4 days. The proposed method for efficient amide formation is a superior alternative to existing coupling methods, opening a door to novel synthesis of MRI contrast agents and beyond.
Subject(s)
Amides , Contrast Media , Porphyrins , Porphyrins/chemistry , Porphyrins/chemical synthesis , Amides/chemistry , Amides/chemical synthesis , Animals , Mice , Contrast Media/chemistry , Contrast Media/chemical synthesis , Magnetic Resonance Imaging , Molecular Structure , Isothiocyanates/chemistry , Fluorescein-5-isothiocyanate/chemistryABSTRACT
The self-assembly of peptides and peptide analogues may be exploited to develop platforms for different biomedical applications, among which CEST-MRI (chemical exchange saturation transfer magnetic resonance imaging) represents one of the most attractive techniques to be explored as a novel metal-free contrast approach in imaging acquisitions. A lysine-containing peptide sequence (LIVAGK-NH2, named K2) was thus modified by insertion, at the N-terminus, of a peptide nucleic acid (PNA) base, leading to a primary amine suitable for the signal generation. a-K2, c-K2, g-K2 and t-K2 peptides were synthesized and characterized. The c-K2 sequence displayed gelling properties and the Watson and Crick pairing, arising from its combination with g-K2, allowed a significant increase in the mechanical responsivity of the hydrogel. These matrices were able to generate a CEST signal around 2.5 ppm from water and, after assessing their cytocompatibility on GL261 (murine glioma), TS/a (murine breast carcinoma), and 3T3-NIH (murine fibroblasts) cell lines, their capability to work as implants for in vivo detection, was proved by intratumor injection in Balb/c mice inoculated with TS/a murine breast cancer cells.
Subject(s)
Contrast Media , Hydrogels , Magnetic Resonance Imaging , Mice, Inbred BALB C , Peptide Nucleic Acids , Peptides , Animals , Hydrogels/chemistry , Hydrogels/chemical synthesis , Mice , Peptide Nucleic Acids/chemistry , Peptides/chemistry , Peptides/chemical synthesis , Contrast Media/chemistry , Contrast Media/chemical synthesis , Female , NIH 3T3 Cells , Cell Line, TumorABSTRACT
Manganese(II)-based contrast agents (MBCAs) are potential candidates for gadolinium-free enhanced magnetic resonance imaging (MRI). In this work, a rigid binuclear MBCA (Mn2-PhDTA2) with a zero-length linker was developed via facile synthetic routes, while the other dimer (Mn2-TPA-PhDTA2) with a longer rigid linker was also synthesized via more complex steps. Although the molecular weight of Mn2-PhDTA2 is lower than that of Mn2-TPA-PhDTA2, their T1 relaxivities are similar, being increased by over 71% compared to the mononuclear Mn-PhDTA. In the presence of serum albumin, the relaxivity of Mn2-PhDTA2 was slightly lower than that of Mn2-TPA-PhDTA2, possibly due to the lower affinity constant. The transmetalation reaction with copper(II) ions confirmed that Mn2-PhDTA2 has an ideal kinetic inertness with a dissociation half-life of approximately 10.4 h under physiological conditions. In the variable-temperature 17O NMR study, both Mn-PhDTA and Mn2-PhDTA2 demonstrated a similar estimated q close to 1, indicating the formation of monohydrated complexes with each manganese(II) ion. In addition, Mn2-PhDTA2 demonstrated a superior contrast enhancement to Mn-PhDTA in in vivo vascular and hepatic MRI and can be rapidly cleared through a dual hepatic and renal excretion pattern. The hepatic uptake mechanism of Mn2-PhDTA2 mediated by SLC39A14 was validated in cellular uptake studies.
Subject(s)
Contrast Media , Liver , Magnetic Resonance Imaging , Manganese , Manganese/chemistry , Liver/diagnostic imaging , Liver/metabolism , Magnetic Resonance Imaging/methods , Animals , Contrast Media/chemistry , Contrast Media/chemical synthesis , Humans , Cation Transport Proteins/metabolism , Cation Transport Proteins/chemistry , Mice , Coordination Complexes/chemistry , Coordination Complexes/chemical synthesisABSTRACT
A novel Fe(III) complex, Fe-tBPCDTA, was synthesized and explored as a potential contrast agent for MRI. Compared to established agents like Fe-EDTA and Fe-tCDTA, Fe-tBPCDTA exhibited moderate relaxivity (r1 = 1.17 s-1·mmol-1) due to its enhanced second-sphere mechanism. It also displayed improved kinetic inertness, lower cytotoxicity, and enhanced redox stability. In vivo studies demonstrated its function as an extracellular fluid agent, providing tumor contrast comparable to that of Gd-DTPA at a higher dosage. Complete renal clearance occurred within 24 h. These findings suggest Fe-tBPCDTA as a promising candidate for further development as a safe and effective extracellular MRI contrast agent.
Subject(s)
Contrast Media , Iron Chelating Agents , Magnetic Resonance Imaging , Organophosphonates , Contrast Media/chemistry , Contrast Media/chemical synthesis , Magnetic Resonance Imaging/methods , Animals , Humans , Organophosphonates/chemistry , Organophosphonates/chemical synthesis , Iron Chelating Agents/chemistry , Iron Chelating Agents/pharmacology , Iron Chelating Agents/chemical synthesis , Ferric Compounds/chemistry , Mice , Cell Line, Tumor , Chelating Agents/chemistry , Chelating Agents/chemical synthesisABSTRACT
A self-immolative radiocontrast polymer agent has been newly designed for this study. The polymer agent is composed of a degradable poly(benzyl ether)-based backbone that enables complete and spontaneous depolymerization upon exposure to a specific stimulus, with iodophenyl pendant groups that confer a radiodensity comparable to that of commercial agents. In particular, when incorporated into a biodegradable polycaprolactone matrix, the agent not only reinforces the matrix and provides prolonged radiopacity without leaching but also governs the overall degradation kinetics of the composite under basic aqueous conditions, allowing for X-ray tracking and exhibiting a predictable degradation until the end of its lifespan. Our design would be advanced with various other components to produce synergistic functions and extended for applications in implantable biodegradable devices and theragnostic systems.
Subject(s)
Contrast Media , Polyesters , Contrast Media/chemistry , Contrast Media/chemical synthesis , Polyesters/chemistry , Polyesters/chemical synthesis , Polymers/chemistry , X-RaysABSTRACT
The current research article has investigated the synthesis and characterization of novel iron nanoparticles (INPs) from neem and betel leaves extract combination using response surface methodology-central composite design and coated with chitosan-curcumin (CCINPs) as a biocompatible and contrast agent for magnetic resonance imaging (MRI). The coating of INPs with chitosan and curcumin (CCINPs) was carried out using a simple, easy, chemical-free ultrasonication method and characteristics were confirmed by UV-visible (Vis) spectrophotometer (UV-Vis), Fourier-transform infrared spectroscopy, X-ray diffraction, scanning electron microscope, atomic force microscopy, and vibrating sample magnetometer. The biocompatibility of the particles was ensured by conducting hemolytic and cell viability assays. The nanoparticle was found to be nonhemolytic (<5%) up to 150 µg/mL for both INPs and CCINPs. The cell viability was stable (peripheral blood mononuclear cells-PBMCs) till 48 h at 150 µg/mL of INPs and CCINPs. Both the test results produced were found to be biocompatible and additionally, an in vitro MRI study of INPs and CCINPs demonstrated the efficiency of the nanoparticle as a negative contrast agent with enhanced contrast nature in CCINPs. Thus, overall results indicate that the green synthesized chemical-free novel CCINPs could be a potential candidate for a wide range of applications such as MRI, drug delivery, and in magnetic fluid hyperthermia.
Subject(s)
Contrast Media , Green Chemistry Technology , Magnetic Resonance Imaging , Contrast Media/chemistry , Contrast Media/chemical synthesis , Contrast Media/pharmacology , Humans , Iron/chemistry , Curcumin/chemistry , Curcumin/pharmacology , Cell Survival/drug effects , Metal Nanoparticles/chemistry , Plant Extracts/chemistry , Chitosan/chemistryABSTRACT
Limited work has been reported on the acoustic and physical characterization of protein-shelled UCAs. This study characterized bovine serum albumin (BSA)-shelled microbubbles filled with perfluorobutane gas, along with SonoVue, a clinically approved contrast agent. Broadband attenuation spectroscopy was performed at room (23 ± 0.5 °C) and physiological (37 ± 0.5 °C) temperatures over the period of 20 min for these agents. Three size distributions of BSA-shelled microbubbles, with mean sizes of 1.86 µm (BSA1), 3.54 µm (BSA2), and 4.24 µm (BSA3) used. Viscous and elastic coefficients for the microbubble shell were assessed by fitting de Jong model to the measured attenuation spectra. Stable cavitation thresholds (SCT) and inertial cavitation thresholds (ICT) were assessed at room and physiological temperatures. At 37 °C, a shift in resonance frequency was observed, and the attenuation coefficient was increased relative to the measurement at room temperature. At physiological temperature, SCT and ICT were lower than the room temperature measurement. The ICT was observed to be higher than SCT at both temperatures. These results enhance our understanding of temperature-dependent properties of protein-shelled UCAs. These findings study may guide the rational design of protein-shelled microbubbles and help choose suitable acoustic parameters for applications in imaging and therapy.
Subject(s)
Contrast Media , Microbubbles , Phospholipids , Serum Albumin, Bovine , Sulfur Hexafluoride , Ultrasonography , Serum Albumin, Bovine/chemistry , Temperature , Contrast Media/chemical synthesis , Contrast Media/chemistry , Phospholipids/chemistry , Sulfur Hexafluoride/chemistry , Acoustics , Particle SizeABSTRACT
A promising clinical trial utilizing gold-silica core-shell nanostructures coated with polyethylene glycol (PEG) has been reported for near-infrared (NIR) photothermal therapy (PTT) of prostate cancer. The next critical step for PTT is the visualization of therapeutically relevant nanoshell (NS) concentrations at the tumor site. Here we report the synthesis of PEGylated Gd2O3-mesoporous silica/gold core/shell NSs (Gd2O3-MS NSs) with NIR photothermal properties that also supply sufficient MRI contrast to be visualized at therapeutic doses (≥108 NSs per milliliter). The nanoparticles have r1 relaxivities more than three times larger than those of conventional T1 contrast agents, requiring less concentration of Gd3+ to observe an equivalent signal enhancement in T1-weighted MR images. Furthermore, Gd2O3-MS NS nanoparticles have r2 relaxivities comparable to those of existing T2 contrast agents, observed in agarose phantoms. This highly unusual combination of simultaneous T1 and T2 contrast allows for MRI enhancement through different approaches. As a rudimentary example, we demonstrate T1/T2 ratio MR images with sixfold contrast signal enhancement relative to its T1 MRI and induced temperature increases of 20 to 55 °C under clinical illumination conditions. These nanoparticles facilitate MRI-guided PTT while providing real-time temperature feedback through thermal MRI mapping.
Subject(s)
Contrast Media , Gadolinium , Gold , Magnetic Resonance Imaging , Nanoshells , Photothermal Therapy , Contrast Media/chemical synthesis , Gadolinium/chemistry , Gold/chemistry , Magnetic Resonance Imaging/methods , Nanoshells/chemistry , Photothermal Therapy/methods , Polyethylene Glycols/chemistry , Silicon Dioxide/chemistryABSTRACT
Metabotropic glutamate receptor 2 (mGluR2) is a therapeutic target for several neuropsychiatric disorders. An mGluR2 function in etiology could be unveiled by positron emission tomography (PET). In this regard, 5-(2-fluoro-4-[11C]methoxyphenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridine-7-carboxamide ([11C]13, [11C]mG2N001), a potent negative allosteric modulator (NAM), was developed to support this endeavor. [11C]13 was synthesized via the O-[11C]methylation of phenol 24 with a high molar activity of 212 ± 76 GBq/µmol (n = 5) and excellent radiochemical purity (>99%). PET imaging of [11C]13 in rats demonstrated its superior brain heterogeneity and reduced accumulation with pretreatment of mGluR2 NAMs, VU6001966 (9) and MNI-137 (26), the extent of which revealed a time-dependent drug effect of the blocking agents. In a nonhuman primate, [11C]13 selectively accumulated in mGluR2-rich regions and resulted in high-contrast brain images. Therefore, [11C]13 is a potential candidate for translational PET imaging of the mGluR2 function.
Subject(s)
Contrast Media/chemistry , Picolinic Acids/chemistry , Pyrans/chemistry , Radiopharmaceuticals/chemistry , Receptors, Metabotropic Glutamate/metabolism , Animals , Brain/diagnostic imaging , Brain/metabolism , Carbon Radioisotopes , Contrast Media/chemical synthesis , Contrast Media/metabolism , Female , Ligands , Macaca fascicularis , Male , Picolinic Acids/chemical synthesis , Picolinic Acids/metabolism , Positron-Emission Tomography , Pyrans/chemical synthesis , Pyrans/metabolism , Radiopharmaceuticals/chemical synthesis , Radiopharmaceuticals/metabolism , Rats, Sprague-DawleyABSTRACT
Complete excision of the last remaining 1-2% of tumor tissue without collateral damage remains particularly challenging. Herein, we report thiophenthiadiazole (TTD)-derived fluorophores L6-PEGnk (n = 1, 2, 5) as new-generation NIR-II (1000-1700 nm) probes with exceptional nonfouling performance and significantly high fluorescence quantum yields in water. L6-PEG2k can self-assemble into vesicular micelles and exhibited minimal immunogenicity, low binding affinities, ultralong blood circulation (t1/2 = 59.5 h), and a supercontrast ratio in vivo. Most importantly, L6-PEG2k achieved excellent in vivo CT-26 and U87MG tumor targeting and accumulation (>20 d) through intraperitoneal or intravenous injection. A subcutaneous U87MG tumor and orthotopic brain glioma were successfully resected under NIR-II FIGS in our animal model via intraperitoneal injection in an extended time window (48-144 h). This study highlights the potential of using L6-PEG2K as self-assembling molecular probes with long-circulation persistence for routine preoperative tumor assessment and precise intraoperative image-guided resection.
Subject(s)
Brain Neoplasms/diagnostic imaging , Contrast Media/chemistry , Fluorescent Dyes/chemistry , Glioma/diagnostic imaging , Spectroscopy, Near-Infrared/methods , Animals , Brain Neoplasms/therapy , Cell Line, Tumor , Contrast Media/chemical synthesis , Contrast Media/pharmacokinetics , Drug Design , Fluorescent Dyes/chemical synthesis , Fluorescent Dyes/pharmacokinetics , Glioma/therapy , Half-Life , Humans , Mice , Mice, Inbred BALB C , Polyethylene Glycols/chemistry , Quantum Theory , Surgery, Computer-Assisted , Tissue Distribution , Transplantation, HeterologousABSTRACT
Silicon particles have garnered attention as promising biomedical probes for hyperpolarized 29Si magnetic resonance imaging and spectroscopy. However, due to the limited levels of hyperpolarization for nanosized silicon particles, microscale silicon particles have primarily been the focus of dynamic nuclear polarization (DNP) applications, including in vivo magnetic resonance imaging (MRI). To address these current challenges, we developed a facile synthetic method for partially 29Si-enriched porous silicon nanoparticles (NPs) (160 nm) and examined their usability in hyperpolarized 29Si MRI agents with enhanced signals in spectroscopy and imaging. Hyperpolarization characteristics, such as the build-up constant, the depolarization time (T1), and the overall enhancement of the 29Si-enriched silicon NPs (10 and 15%), were thoroughly investigated and compared with those of a naturally abundant NP (4.7%). During optimal DNP conditions, the 15% enriched silicon NPs showed more than 16-fold higher enhancementsâfar beyond the enrichment ratioâthan the naturally abundant sample, further improving the signal-to-noise ratio in in vivo 29Si MRI. The 29Si-enriched porous silicon NPs used in this work are potentially capable to serve as drug-delivery vehicles in addition to hyperpolarized 29Si in vivo, further enabling their potential future applicability as a theragnostic platform.
Subject(s)
Biomimetic Materials/chemistry , Contrast Media/chemistry , Magnetic Resonance Imaging , Nanoparticles/chemistry , Phantom Limb/diagnostic imaging , Silicon/chemistry , Animals , Biomimetic Materials/administration & dosage , Biomimetic Materials/chemical synthesis , Contrast Media/administration & dosage , Contrast Media/chemical synthesis , Isotopes , Male , Materials Testing , Mice , Mice, Inbred BALB C , Mice, Nude , Nanoparticles/administration & dosage , Particle Size , Porosity , Silicon/administration & dosageABSTRACT
Single-modal magnetic resonance imaging (MRI) contrast agents sometimes cause signal confusion in clinical diagnosis. Utilizing ligands to endow iron oxide nanoparticles (IO NPs) with excellent dual-modal MRI contrast efficiency might be an effective strategy to improve diagnostic accuracy. This work presents the development of a special ligand-assisted one-pot approach for the preparation of super-hydrophilic magnetic NPs with excellent water dispersion, biocompatibility and T1-T2 dual-modal contrast enhancement properties. In addition, the strong binding capacity between the ethylenediamine tetramethylenephosphonic acid (EDTMP) ligand and water molecules induced by the presence of abundant hydrogen bonds significantly improves spin-lattice (T1) and spin-spin (T2) imaging of the IO core. After being modified with the EDTMP ligand, the T2 relaxation rate of the IO core is dramatically increased from 71.78 mM-1 s-1 to 452.38 mM-1 s-1, and a moderate T1 relaxation rate (11.61 mM-1 s-1) is observed simultaneously, implying that the NPs with an average size of 9.7 nm may be potential candidates as high-efficiency T1-T2 MRI contrast agents. This fundamental technique of using super-hydrophilicity ligands to endow IO NPs with dual-modal contrast properties without size change and damage in the T2 contrast effect may provide a useful strategy to facilitate the application of magnetic NPs in the field of medical diagnosis.
Subject(s)
Biocompatible Materials/chemistry , Contrast Media/chemistry , Magnetic Iron Oxide Nanoparticles/chemistry , Magnetic Resonance Imaging , Organophosphorus Compounds/chemistry , Water/chemistry , 3T3 Cells , Animals , Biocompatible Materials/administration & dosage , Biocompatible Materials/chemical synthesis , Contrast Media/administration & dosage , Contrast Media/chemical synthesis , Hemolysis , Ligands , Magnetic Iron Oxide Nanoparticles/administration & dosage , Mice , Organophosphorus Compounds/administration & dosage , Particle Size , Surface PropertiesABSTRACT
Dysfunctional elastin turnover plays a major role in the progression of atherosclerotic plaques. Failure of tropoelastin cross-linking into mature elastin leads to the accumulation of tropoelastin within the growing plaque, increasing its instability. Here we present Gd4-TESMA, an MRI contrast agent specifically designed for molecular imaging of tropoelastin within plaques. Gd4-TESMA is a tetrameric probe composed of a tropoelastin-binding peptide (the VVGS-peptide) conjugated with four Gd(III)-DOTA-monoamide chelates. It shows a relaxivity per molecule of 34.0 ± 0.8 mM-1 s-1 (20 MHz, 298 K, pH 7.2), a good binding affinity to tropoelastin (KD = 41 ± 12 µM), and a serum half-life longer than 2 h. Gd4-TESMA accumulates specifically in atherosclerotic plaques in the ApoE-/- murine model of plaque progression, with 2 h persistence of contrast enhancement. As compared to the monomeric counterpart (Gd-TESMA), the tetrameric Gd4-TESMA probe shows a clear advantage regarding both sensitivity and imaging time window, allowing for a better characterization of atherosclerotic plaques.
Subject(s)
Atherosclerosis/metabolism , Contrast Media/chemistry , Elastin/metabolism , Gadolinium/chemistry , Magnetic Resonance Imaging , Tropoelastin/analysis , Animals , Contrast Media/chemical synthesis , Disease Models, Animal , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Molecular Structure , Surface Plasmon ResonanceABSTRACT
Here, the synthesis of sub-micron MMnF3 (M = Na or K) particles by a rapid microwave-assisted approach is reported. Adjustment of the Na+-to-Mn2+ ratio in the reaction mixture yielded tuneable morphologies, i.e., rods, ribbons, and plates. Relaxometric results indicated that poly(acrylic acid)-capped MMnF3 particles exhibited characteristic magnetic properties, which endows them with potential T1-weighted contrast agent capabilities.
Subject(s)
Contrast Media/chemical synthesis , Fluorides/chemical synthesis , Manganese Compounds/chemical synthesis , Nanotubes/chemistry , Magnetic Phenomena , MicrowavesABSTRACT
Modern polymer science suffers from the curse of multidimensionality. The large chemical space imposed by including combinations of monomers into a statistical copolymer overwhelms polymer synthesis and characterization technology and limits the ability to systematically study structure-property relationships. To tackle this challenge in the context of 19F magnetic resonance imaging (MRI) agents, we pursued a computer-guided materials discovery approach that combines synergistic innovations in automated flow synthesis and machine learning (ML) method development. A software-controlled, continuous polymer synthesis platform was developed to enable iterative experimental-computational cycles that resulted in the synthesis of 397 unique copolymer compositions within a six-variable compositional space. The nonintuitive design criteria identified by ML, which were accomplished by exploring <0.9% of the overall compositional space, lead to the identification of >10 copolymer compositions that outperformed state-of-the-art materials.
Subject(s)
Contrast Media/chemistry , Polymers/chemistry , Contrast Media/chemical synthesis , Fluorine/chemistry , Machine Learning , Magnetic Resonance Imaging , Polymers/chemical synthesis , Software , SolubilityABSTRACT
Fe(III) macrocyclic complexes containing a macrocycle and three pendant groups including phosphonate (NOTP =1,4,7-triazacyclononane-1,4,7-triyl-tris(methylenephosphonic acid), carboxylate (NOTA = 1,4,7 - triazacyclononane - N,N',Nâ³ - triacetate) or hydroxypropyl (NOHP =(2S,2'S,2"S)-1,1',1â³-(1,4,7-triazonane-1,4,7-triyl)tris(propan-2-ol)) were studied in order to compare the effect of these donor groups on solution chemistry and water proton relaxivity. All three complexes, Fe(NOTP), Fe(NOHP) and Fe(NOTA), display a large degree of kinetic inertness to dissociation in the presence of phosphate and carbonate, under acidic conditions of 100 mM HCl or 1 M HCl or to trans-metalation with Zn(II). The r1 proton relaxivity of the complexes at 1.4 T, 33 °C is compared over the pH range of 1 to 10. At pH 7.4, 33 °C, 1.4 T, Fe(NOHP) has the largest relaxivity (1.5 mM-1 s-1), Fe(NOTP) is second at 1.0 mM-1 s-1, whereas Fe(NOTA) is the lowest at 0.61 mM-1 s-1. Fe(NOTP), Fe(NOHP) and Fe(NOTA) all show an increase in relaxivity at very acidic pH values (< 3) that is consistent with an acid-catalyzed process. Variable temperature 17O NMR studies at near neutral pH are consistent with the absence of an inner-sphere water molecule for Fe(NOTP) and Fe(NOHP), supporting second-sphere or outer-sphere water contributions to proton relaxation. Fe(NOTP) shows contrast enhancement in T1 weighted MRI studies in mice and clears through a renal pathway.
Subject(s)
Contrast Media/chemistry , Coordination Complexes/chemistry , Animals , Contrast Media/chemical synthesis , Contrast Media/pharmacokinetics , Coordination Complexes/chemical synthesis , Coordination Complexes/pharmacokinetics , Heterocyclic Compounds, 1-Ring/chemical synthesis , Heterocyclic Compounds, 1-Ring/chemistry , Heterocyclic Compounds, 1-Ring/pharmacokinetics , Iron/chemistry , Ligands , Magnetic Resonance Imaging , Mice, Inbred BALB C , Molecular Structure , Phosphorous Acids/chemical synthesis , Phosphorous Acids/chemistry , Phosphorous Acids/pharmacokinetics , Water/chemistryABSTRACT
The particular characteristics of hypoxia, immune suppression in the tumor microenvironment, and the lack of accurate imaging guidance lead to the limited effects of stereotactic body radiotherapy (SBRT) in reducing the recurrence rate and mortality of hepatocellular carcinoma (HCC). This research developed a novel theranostic agent based on Bi/Se nanoparticles (NPs), synthesized by a simple reduction reaction method for in vivo CT image-guided SBRT sensitization in mice. After loading Lenvatinib (Len), the obtained Bi/Se-Len NPs had excellent performance in reversing hypoxia and the immune suppression status of HCC. In vivo CT imaging results uncovered that the radiotherapy (RT) area could be accurately labeled after the injection of Bi/Se-Len NPs. Under Len's unique and robust properties, in vivo treatment was then carried out upon injection of Bi/Se-Len NPs, achieving excellent RT sensitization effects in a mouse HCC model. Comprehensive tests and histological stains revealed that Bi/Se-Len NPs could reshape and normalize tumor blood vessels, reduce the hypoxic situation of the tumor, and upregulate tumor-infiltrating CD4+ and CD8+ T lymphocytes around the tumors. Our work highlights an excellent proposal of Bi/Se-Len NPs as theranostic nanoparticles for image-guided HCC radiotherapy.
Subject(s)
Antineoplastic Agents/therapeutic use , Carcinoma, Hepatocellular/drug therapy , Contrast Media/therapeutic use , Liver Neoplasms/drug therapy , Metal Nanoparticles/therapeutic use , Tumor Microenvironment/drug effects , Animals , Bismuth/chemistry , Bismuth/therapeutic use , Bismuth/toxicity , Blood Vessels/drug effects , Carcinoma, Hepatocellular/diagnostic imaging , Cell Line, Tumor , Contrast Media/chemical synthesis , Contrast Media/toxicity , Drug Carriers/chemical synthesis , Drug Carriers/therapeutic use , Drug Carriers/toxicity , Female , Humans , Hypoxia/drug therapy , Liver Neoplasms/diagnostic imaging , Lymphocytes/drug effects , Metal Nanoparticles/chemistry , Metal Nanoparticles/toxicity , Mice, Inbred BALB C , Phenylurea Compounds/therapeutic use , Precision Medicine , Quantum Dots/chemistry , Quantum Dots/therapeutic use , Quantum Dots/toxicity , Quinolines/therapeutic use , Radiation-Sensitizing Agents/chemical synthesis , Radiation-Sensitizing Agents/therapeutic use , Radiation-Sensitizing Agents/toxicity , Radiosurgery , Selenium/chemistry , Selenium/therapeutic use , Selenium/toxicity , Tomography, X-Ray ComputedABSTRACT
Gd-based complexes are widely used as magnetic resonance imaging (MRI) contrast agents. The safety of previously approved contrast agents is questionable and is being re-assessed. The main causes of concern are possible gadolinium deposition in the brain and the development of systemic nephrogenic fibrosis after repeated use of MRI contrasts. Thus, there is an urgent need to develop a new generation of MRI contrasts that are safe and that have high selectivity in tissue accumulation with improved local contrast. Here, we report on a new type of theranostic MRI contrast, namely dextran stabilised, gadolinium doped cerium dioxide nanoparticles. These ultra-small (4-6 nm) Ce0.9Gd0.1O1.95 nanoparticles have been shown to possess excellent colloidal stability and high r1-relaxivity (3.6 mM-1 s-1). They are effectively internalised by human normal and cancer cells and demonstrate dose-dependent selective cytotoxicity to cancer cells.
Subject(s)
Antioxidants/pharmacology , Biocompatible Materials/pharmacology , Contrast Media/pharmacology , Magnetic Resonance Imaging , Nanoparticles/chemistry , Antioxidants/chemical synthesis , Antioxidants/chemistry , Biocompatible Materials/chemical synthesis , Biocompatible Materials/chemistry , Cell Survival/drug effects , Cells, Cultured , Cerium/chemistry , Cerium/pharmacology , Contrast Media/chemical synthesis , Contrast Media/chemistry , Dextrans/chemistry , Dextrans/pharmacology , Dose-Response Relationship, Drug , Gadolinium/chemistry , Gadolinium/pharmacology , Humans , Materials Testing , Membrane Potential, Mitochondrial/drug effects , Particle Size , Reactive Oxygen Species/metabolismABSTRACT
Cisplatin and related Pt(II) chemotherapeutics are indispensable tools for the treatment of various solid tumors. Despite their widespread clinical use in approximately 50 % of chemotherapy regimens, they are hindered by issues with off-target toxicity and chemoresistance, both innate and acquired. To date, there is no effective way to predict the outcome of Pt(II) chemotherapy because the genes associated with resistance are not completely known or understood. Instead, patients undergo weeks to months of potentially harmful therapy before knowing if it is effective. Here we report two Gd(III)-Pt(II) theranostic MR contrast agents that contain cisplatin and carboplatin-based moieties respectively. We used these agents to demonstrate that accumulation differences in Pt(II) sensitive and resistant cells, a dominant factor in chemoresistance, can be imaged by MR. Both theranostic agents bind to DNA, are cytotoxic, and enhance the intracellular T1 -weighted MR contrast of multiple cell lines. Most importantly, the cisplatin-based agent accumulates less in Pt(II) resistant cells inâ vitro and inâ vivo, resulting in decreased MR contrast enhancement compared to the parent Pt(II) sensitive cell line. This straightforward method to image a key factor of Pt(II) resistance using MRI is an important first step towards the ultimate goals of predicting response to Pt(II) chemotherapy and monitoring for the onset of chemoresistance - a critical unmet need in medicine that could significantly improve patient outcomes.